Regression models for analyzing costs and their determinants in health care: an introductory review

被引:119
作者
Gregori, Dario [1 ]
Petrinco, Michele [2 ,3 ]
Bo, Simona [4 ]
Desideri, Alessandro [5 ]
Merletti, Franco [2 ,3 ]
Pagano, Eva [2 ,3 ]
机构
[1] Univ Padua, Dept Environm Med & Publ Hlth, Labs Epidemiol Methods & Biostat, I-35121 Padua, Italy
[2] Univ Turin, Canc Epidemiol Unit, Turin, Italy
[3] CPO Piemonte, Turin, Italy
[4] Univ Turin, Dept Internal Med, Turin, Italy
[5] Castelfranco Veneto Hosp, Unit Cardiol, Padua, Italy
关键词
cost analysis; skewness; zero-cost; censoring; BOOTSTRAP-CONFIDENCE-INTERVALS; CLINICAL-TRIAL DATA; EFFECTIVENESS ACCEPTABILITY CURVES; ESTIMATING MEDICAL COSTS; EFFECTIVENESS RATIOS; HOSPITAL COSTS; CENSORED-DATA; STATISTICAL-INFERENCE; MYOCARDIAL-INFARCTION; ALTERNATIVE MODELS;
D O I
10.1093/intqhc/mzr010
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
This article aims to describe the various approaches in multivariable modelling of healthcare costs data and to synthesize the respective criticisms as proposed in the literature. We present regression methods suitable for the analysis of healthcare costs and then apply them to an experimental setting in cardiovascular treatment (COSTAMI study) and an observational setting in diabetes hospital care. We show how methods can produce different results depending on the degree of matching between the underlying assumptions of each method and the specific characteristics of the healthcare problem. The matching of healthcare cost models to the analytic objectives and characteristics of the data available to a study requires caution. The study results and interpretation can be heavily dependent on the choice of model with a real risk of spurious results and conclusions.
引用
收藏
页码:331 / 341
页数:11
相关论文
共 98 条
[61]  
Nease DE, 1999, J FAM PRACTICE, V48, P769
[62]   Analysis of uncertainty in health care cost-effectiveness studies: an introduction to statistical issues and methods [J].
O'Brien, BJ ;
Briggs, AH .
STATISTICAL METHODS IN MEDICAL RESEARCH, 2002, 11 (06) :455-468
[63]   Incorporation of uncertainty in health economic modelling studies [J].
O'Hagan, A ;
McCabe, C ;
Akehurst, R ;
Brennan, A ;
Briggs, A ;
Claxton, K ;
Fenwick, E ;
Fryback, D ;
Sculpher, M ;
Spiegelhalter, D ;
Willan, A .
PHARMACOECONOMICS, 2005, 23 (06) :529-536
[64]   On estimators of medical costs with censored data [J].
O'Hagan, A ;
Stevens, JW .
JOURNAL OF HEALTH ECONOMICS, 2004, 23 (03) :615-625
[65]   Inference for the cost-effectiveness acceptability curve and cost-effectiveness ratio [J].
O'Hagan, A ;
Stevens, JW ;
Montmartin, J .
PHARMACOECONOMICS, 2000, 17 (04) :339-349
[66]   Bayesian methods for design and analysis of cost-effectiveness trials in the evaluation of health care technologies [J].
O'Hagan, A ;
Stevens, JW .
STATISTICAL METHODS IN MEDICAL RESEARCH, 2002, 11 (06) :469-490
[67]   Assessing and comparing costs: how robust are the bootstrap and methods based on asymptotic normality? [J].
O'Hagan, A ;
Stevens, JW .
HEALTH ECONOMICS, 2003, 12 (01) :33-49
[68]   A framework for cost-effectiveness analysis from clinical trial data [J].
O'Hagan, A ;
Stevens, JW .
HEALTH ECONOMICS, 2001, 10 (04) :303-315
[69]   Bayesian cost-effectiveness analysis from clinical trial data [J].
O'Hagan, A ;
Stevens, JW ;
Montmartin, J .
STATISTICS IN MEDICINE, 2001, 20 (05) :733-753
[70]   The probability of cost-effectiveness [J].
O'Hagan A. ;
Stevens J.W. .
BMC Medical Research Methodology, 2 (1) :1-6